Pharmacological interventions for antisocial personality disorder

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Psychology

Background:

• Antisocial personality disorder (AsPD) is linked to significant life disturbances, including rule-breaking, criminality, substance misuse, unemployment, homelessness, and relationship issues.
• Current understanding of pharmacological interventions for AsPD is limited.

Purpose of the Study:

• To systematically evaluate the potential benefits and adverse effects of pharmacological interventions for individuals diagnosed with antisocial personality disorder (AsPD).

Main Methods:

• Conducted a comprehensive literature search across multiple databases for controlled trials of pharmacological interventions versus placebo in AsPD patients.
• Included studies with randomized allocation to pharmacological treatment or placebo.
• Extracted data and performed statistical analyses, including calculating mean differences and odds ratios.

Main Results:

• Eight studies involving 394 participants met inclusion criteria, but data from only 274 were available for analysis.
• Study quality was generally poor, with inadequate reporting hindering independent statistical analysis.
• Limited findings suggest potential efficacy for nortriptyline, bromocriptine, and phenytoin in specific outcomes, but results are based on single, unreplicated reports.

Conclusions:

• The available evidence is insufficient to draw definitive conclusions regarding the efficacy of pharmacological interventions for antisocial personality disorder (AsPD).
• Further high-quality research is necessary to establish effective pharmacological treatments for AsPD.